In the courses of our search for bioactive natural products on TRAIL resistance-overcoming activity, the active EtOAc extract from the bark of Celtis tetrandra was chemically investigated. The fractionation of the extract resulted in the isolation of flavanols; (+)-afzelechin (1), (-)-epiafzelechin (2), (-)-catechin (3), and two new flavanol dimers; (-)-epiafzelechin-(4α→8)-(-)-catechin (4) and (-)-epiafzelechin-(4α→8)-(-)-epicatechin (5). All isolated compounds 1-5 were tested for their TRAIL resistance-overcoming activity against AGS cells at the concentrations from 5–20 μM. It is likely that the flavanol dimers 4 and 5 exhibited weak activity in the range of the concentration of 10–20 μM as compared with the standard.
JunsongduangA., BalslevH., IntaA., JampeetongA., WangpakapattanawongP. (2013) Medicinal plants from swidden fallows and sacred forest of the Karen and the Lawa in Thailand. Journal of Ethnobiology and Ethnomedicine, 9, 44–54.
2.
SpitalerR., GurschlerS., EllmererP.E., SchubertB., SgarbossaM., ZidornC. (2009) Flavonoids from Celtis australis (Canabeceae). Biochemical and Systematics and Ecology, 37, 120–121.
3.
KaltenhauserM., EllmererE.P., ZidornC. (2010) Rhamnopyranosylvitexin derivatives from Celtis australis. Journal of the Serbian Chemical Society, 75, 733–738.
4.
ZehrmannN., ZidornC., GanzeraM. (2010) Analysis of rare flavonoid C-glycosides in Celtis australis L. by micellar electrokinetic chromatography. Journal of Pharmaceutical and Biomedical Analysis, 51, 1165–1168.
5.
BadoniR., SemwalD.K., RawatU., SinghG.J.P. (2010) Celtisanin, a novel sulphonated phenolic from Celtis australis L. fruits. Natural Product Research, 24, 1282–1286.
6.
El-AlfyT.S., El-GoharyH.M.A., SokkarN.M., HosnyM., Al-MahdyD.A. (2011) A new flavonoid C-glycoside from Celtis australis L. and Celtis occidentalis L. leaves and potential antioxidant and cytotoxic activities. Scientia Pharmaceutoca, 79, 963–975.
7.
BadoniR., SemwalD.K., BadoniP.P., KothiyalS.K., RawatU. (2011) A novel bacteriohopanoid from Celtis australis L. bark. Chinese Chemical Letters, 22, 81–84.
8.
JohnstoneR.W., FrewA.J., SmythM.J. (2008) The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nature Reviews Cancer, 8, 782–798.
9.
MiyagawaT., OhtsukiT., KoyanoT., KowithayakornT., IshibashiM. (2009) Cardenolide glycoside of Thevetia peruviana and triterpenoid saponins of Sapindus emarginatus as TRAIL resistance-overcoming compounds. Journal of Natural Products, 72, 1507–1511.
10.
KikuchiH., OhtsukiT., KoyanoT., KowithayakornT., SakaiT., IshibashiM. (2010) Activity of mangosteen xanthones and teleocidin A-2 in death receptor expression enhancement and tumor necrosis factor related apoptosis-inducing kigand assays. Journal of Natural Products, 73, 452–455.
11.
MinakawaT., ToumeK., AraiM.A., SadhuS.K., AhmedF., IshibashiM. (2012) Eudesmane-type sesquiterpenoid and guaianolides from Kandelia candel in a screening program for compounds to overcome TRAIL resistance. Journal of Natural Products, 75, 1431–1435.
12.
ToumeK., HabuT., AraiM.A., KoyanoT., KowithayakornT., IshibashiM. (2015) Prenylated flavonoids and resveratrol derivatives isolated from Artocarpus communis with the ability to overcome TRAIL resistance. Journal of Natural Products, 78, 103–110.
13.
KarmakarU.K., IshikawaN., AraiM.A., AhmedF., KoyanoT., KowithayakornT., IshibashiM. (2016) Boesenberols, pimarane derivatives with TRAIL-resistance overcoming activity from Boesenbergia pandurata. Journal of Natural Products, 79, 2075–2082.
14.
SaijyoJ., SuzukiY., OkunoY., YamakiH., SuzukiT., MiyazawaM. (2008) α-Glucosidase inhibitor from Bergenia ligulata. Journal of Oleo Science, 57, 431–435.
15.
WanS.B., ChanT.H. (2004) Enantioselective synthesis of afzelechin and epiafzelechin. Tetrahedron, 60, 8207–8211.
16.
El-RazekM.H.A. (2007) NMR assignments of four catechin epimers. Asian Journal of Chemistry, 19, 4867–4872.
17.
RinaldoD., BatistaJ.M.Jr, RodriguesJ., BenfattiA.C., RodriquesC.M., Dos SantosL.C., FurlanM., VilegasW. (2010) Determination of catechin diastereomers from the leaves of Byrsonima species using chiral HPLC-PAD-CD. Chirality, 22, 726–733.
18.
ShahatA.A. (2006) Procyanidins from Adansonia digitata. Pharmaceutical Biology, 44, 445–450.
19.
KashiwadaY., IizukaH., YoshiokaK., ChenR.F., NonakaG., NishiokaI. (1990) Tannins and related compounds. XCII.1) Occurrence of enantiomeric proanthocyanidins in the Leguminosae plants, Cassia fistula L. and C. javanica L. Chemical and Pharmaceutical Bulletin, 38, 888–893.
20.
KofinkM., PapagiannopoulosM., GalensaR. (2007) (-)-Catechin in cocoa and chocolate: Occurrence and analysis of an atypical flavan-3-ol enantiomer. Molecules, 12, 1274–1288.
21.
RagabE.A., MohammedAesi, AbbassH.S., KotbS.I. (2013) A new flavan-3-ol dimer from Ficus spragueana leaves and its cytotoxic activity. Pharmacognosy Magazine, 9, 144–148.
22.
LingY., YeM., YangW., QiaoX., WangQ., YangH., WangX., GuoD. (2011) Flavan-3-ols from the rhizomes of Drynaria fortunei. Phytochemistry, 72, 1876–1882.
23.
BickerJ., PetereitF., HenselA.Proanthocyanidins and a phloroglucinol derivative from Rumex acetosa L. (2009) Fitoterapia, 80, 483–495.
24.
TaniguchiS., KurodaK., DoiK., TanabeM., ShibataT., YoshidaT., HatanoT. (2007) Revised structures of gambiriins A1, A2, B1 and B2, chalcane-flavan diners from Gambir (Uncaria gambir extract). Chemical and Pharmaceutical Bulletin, 55, 268–272.
25.
LingS.K., FukumoriS., TomiiK., TanakaT., KounoI. (2006) Isolation, purification and identification of chemical constituents from Elateriospermum tapos. Journal of Tropical Forest Science, 18, 81–85.
26.
AhmedF., IshibashiM. (2016) Recent progress in study on biological active natural products; Bioactive natural product with TRAIL-resistant overcoming activity. Chemical and Pharmaceutical Bulletin, 64, 119–127.
27.
HorinakaM., YoshidaT., ShiraishiT., NakataS., WakadaM., NakanishiR., NishinoH., SakaiT. (2005) The combination of TRAIL and luteolin enhance apoptosis in human cervical cancer Hela cells. Biochemical Biophysical Research Communications, 333, 833–838.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
